Kenya Sino-implant (II) PK Study
NCT01930994 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2013-10-14
Summary
A cross-sectional study to compare pharmacokinetics of Sino-implant (II) during four years of used and Jadelle during five years of use by Kenyan women.
Conditions
- Contraception
Sponsors & Collaborators
-
Marie Stopes International
collaborator OTHER -
FHI 360
lead OTHER
Principal Investigators
-
Mark Ayallo, MD · Marie Stopes Kenya
Eligibility
- Min Age
- 18 Years
- Max Age
- 44 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- Kenya
Study Locations
More Related Trials
-
Assessing Ovarian Function During Prolonged Implant Use
NCT03058978 ·Status: COMPLETED
-
A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)
NCT04626596 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Isotretinoin on the Etonogestrel Contraceptive Implant
NCT02967055 ·Status: COMPLETED
-
The Amenorrhea With Etonogestrel Implant
NCT05040282 ·Status: COMPLETED ·Phase: NA
-
A Multicenter Trial to Evaluate the Insertion Characteristics of the Radiopaque Etonogestrel Implant Using a Next Generation Applicator (34530)(P05702)
NCT00620035 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone
NCT02652650 ·Status: COMPLETED ·Phase: PHASE1
-
Shoulder Contraceptive Implant Study
NCT04463693 ·Status: COMPLETED ·Phase: PHASE4
-
Injectable Contraception Cohort Study in Punjab, Pakistan
NCT05774626 ·Status: COMPLETED
-
Postpartum Etonogestrel Implant for Adolescents
NCT01666912 ·Status: COMPLETED ·Phase: PHASE4
-
A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women
NCT01953809 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study to Investigate the Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone in Healthy Females
NCT03126097 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive
NCT03506399 ·Status: WITHDRAWN ·Phase: PHASE1
-
Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive Implant
NCT02353247 ·Status: COMPLETED ·Phase: NA
-
Long Term Evaluation of Scapular-inserted Contraceptive Implants
NCT07201402 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Adult Participants
NCT03249402 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Estimate The Effect of PF-06650833 On The Pharmacokinetics (PK) of Oral Contraceptive (OC)
NCT05064332 ·Status: COMPLETED ·Phase: PHASE1
-
Endometrial Biopsy in Progestin Contraceptive Users
NCT05760144 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive
NCT01963403 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of Evobrutinib on Pharmacokinetics of a Combined Oral Contraceptive
NCT07215806 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of One-to-one Service on the Continuation and Satisfaction of Contraceptive Use.
NCT05362019 ·Status: UNKNOWN ·Phase: NA
-
Study of Safety and Efficacy of an Oral Contraceptive
NCT00391807 ·Status: COMPLETED ·Phase: PHASE3
-
Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive
NCT00196326 ·Status: COMPLETED ·Phase: PHASE3
-
Casea S Contraceptive Implants (Casea S) Trial
NCT05174884 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant
NCT06461039 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial of Efficacy, Safety and Tolerability of LVDS (Levonorgestrel Vaginal Delivery System) During 13 Cycles
NCT06019533 ·Status: COMPLETED ·Phase: PHASE3